Sign inSubscribe
Add location
Pfizer/BioNTech to supply vaccines for Olympic athletes
06 May
US drugs giantPfizerand its German partnerBioNTechon Thursday announced a deal with the International Olympic Committee (IOC) to provide vaccines to competitors and staff at theTokyo Games.
In a statement, the firms said they would coordinate with national sporting bodies to make sure that coronavirus vaccines are available to anyone who needs one before travelling to Japan.
"Delivery of initial doses to participating delegations is expected to begin at the end of May where possible with the aim to ensure participating delegations receive second doses ahead of arrivals in Tokyo," they said.
The agreement was welcomed by IOC president Thomas Bach, who has already seen the Tokyo Games postponed from last year because of the pandemic.
"We are inviting the athletes and participating delegations of the upcoming Olympic and Paralympic Games to lead by example and accept the vaccine where and when possible," Bach said.
There are expected to be more than 11,000 athletes at the games, which will run from 23 July to 8 August, but many have already secured vaccines in their home countries.
The IOC has been promising for months that the Olympics would be safe even without widespread vaccination, thanks to a battery of health precautions. 
The IOC has already said it will offer national delegations Covid-19 vaccines bought from China.
But the agreement with Pfizer is seen as important as Tokyo and several Japanese regions are once again under a state of alert due to the increase in cases of Covid-19, amid lingering doubts about the wisdom of holding the games. 
Behind closed doors?
This video is either unavailable or not supported in this browser
Session ID: 2021-06-15:f7ac15ba312acb7ada8c1437 Player Element ID: brightcove6252891485001
1m 10s
Team GB kit revealed ahead of Olympic and Paralympic Games
The new Adidas kit for Great Britain's athletes to wear during the Tokyo 2020 Olympics and Paralympics vhas been unveiled.
Japan has already decided to ban spectators from abroad and the president of the organising committee, Seiko Hashimoto, told AFP last Friday that the Olympics could be held behind closed doors for the first time in their history.  
With Japan's hospital system already under intense pressure, Tokyo 2020 has been criticised for asking Japanese medical staff to work on the event, and Hashimoto said the absence of spectators could ease the pressure. 
In an attempt to appease the scepticism of the Japanese public, organisers last week tightened the anti-virus measures imposed on both Olympic delegations and the media. 
Albert Bourla, chairperson and CEO of Pfizer and Ugur Sahin or BioNTech said their firms were proud to supply the vaccine - already the mainstay of Europe's inoculation effort - to the Games. 
"The return of the Olympic and Paralympic Games represents a monumental moment of world unity and peace after a gruelling year of isolation and devastation," Bourla said.
Bourla made the proposal to Japanese Prime Minister Yoshihide Suga last month when the two held telephone talks during Suga's visit to the US, Japan's Olympic Minister Tamayo Marukawa said.
More videos related to Olympics
Play video on original page

Tokyo Olympic Games To Prohibit Athletes From Wearing BLM Clothing
Play video on original page
"We received a very important offer in order to proceed with safe and secure Games," Marukawa told reporters in Tokyo.
The firms noted that it would be a decision of individual countries' government whether to permit or require the vaccines to be used, but added that the jab has been authorised by the EU, US, UK, Canada and other countries.
We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
We use cookies to improve your site experience, perform analytics and show you relevant advertising. By clicking “OK”, you agree to the storing of cookies on your device. View our cookie policy